|
業務類別
|
Biotechnology |
|
業務概覽
|
Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases. |
| 公司地址
| 400 East Jamie Court, Suite 200, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 392-3357 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.lyciatx.com |
| 員工數量
| 31 |
| Dr. Aetna Wun Trombley, PhD |
President, Chief Executive Officer and Director |
-- |
05/10/2026 |
| Dr. Chin Lee, M.D.,M.P.H. |
Chief Medical Officer |
-- |
05/10/2026 |
| Ms. Amy Bachrodt |
Chief Financial Officer |
-- |
05/10/2026 |
| Mr. Steve Staben, PhD |
Chief Scientific Officer |
-- |
05/10/2026 |
| Dr. Sofia Touami |
Chief Business Officer |
-- |
05/10/2026 |
|
|
| Ms. Jane Pritchett Henderson |
Independent Director |
05/10/2026 |
| Mr. William J. Rieflin |
Chairman of the Board |
05/10/2026 |
| Dr. Laurent Fischer, M.D. |
Independent Director |
05/10/2026 |
| Dr. Aetna Wun Trombley, PhD |
President, Chief Executive Officer and Director |
05/10/2026 |
| Dr. Clare Ozawa, PhD |
Independent Director |
05/10/2026 |
| Mr. Tim Anderson |
Independent Director |
05/10/2026 |
| Mr. Ming Fang |
Independent Director |
05/10/2026 |
|
|
|
|